Why Complete Dose Availability Matters for Your Journey
Complete Wegovy and Mounjaro Dose Comparison: Full Range Analysis
When comparing Wegovy and Mounjaro dosing regimens, understanding the complete escalation pathway is crucial for treatment success. Wegovy follows a 5-dose escalation from 0.25mg through to 2.4mg maintenance, whilst Mounjaro uses a 4-dose schedule reaching 15mg maximum. Both treatments require mandatory dose increases every 4 weeks, making continuous supply availability essential. EverydayMeds stocks every single dose strength of both medications, ensuring patients never face treatment interruptions due to supply shortages.
The dosing comparison reveals key practical differences beyond just strength variations. Wegovy's longer escalation period spans 16 weeks before reaching maintenance, allowing for gradual tolerance building. Mounjaro reaches therapeutic doses more quickly, with many patients achieving significant results by the 10mg dose at week 9. Both approaches have clinical justification, and your prescriber can determine which dosing philosophy aligns better with your treatment goals and tolerance profile.
Wegovy vs Mounjaro Pricing and Value Across All Dose Strengths
Understanding the complete cost implications of Wegovy and Mounjaro dose comparison requires examining pricing across all treatment phases. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing to £209.99 for the 2.4mg maintenance strength. Our bundle options like the Intro Trio (0.25mg, 0.5mg & 1mg) at £299.99 provide convenient multi-dose packages. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 to reach these final prices.
Mounjaro pricing follows a different structure, with costs varying based on the dual-agonist formulation complexity. The financial commitment extends beyond individual pen costs to consider long-term maintenance pricing. Our Ultimate Stability Trio provides three months of maintenance supply at £649.99, offering treatment continuity without repeated ordering. The investment in complete dose availability ensures patients never compromise their treatment momentum due to supply limitations or pharmacy switching costs.
Clinical Evidence for Wegovy and Mounjaro Dose Effectiveness
The STEP clinical trial programme demonstrated Wegovy's dose-dependent efficacy across its complete range. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks. The dose escalation protocol proved essential, with optimal results occurring at the full 2.4mg maintenance dose.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, showing the importance of its complete dose range for maximising therapeutic benefit. The dual GIP and GLP-1 receptor agonist mechanism demonstrated dose-related improvements, with higher strengths providing enhanced efficacy. Both medications require their full prescribed dose ranges to achieve the clinical outcomes demonstrated in these pivotal studies.
How Wegovy Works: Complete Mechanism Across All Doses
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. This mechanism works by binding to GLP-1 receptors in the brain's appetite control centres, promoting feelings of satiety and reducing food cravings. The dose escalation from 0.25mg to 2.4mg allows for gradual receptor engagement, minimising side effects whilst building therapeutic effect. Each dose increase enhances the medication's ability to regulate appetite signals and slow gastric emptying. The complete dose range ensures optimal receptor saturation for maximum therapeutic benefit whilst maintaining tolerability throughout the treatment journey.
Streamlined Ordering Process for Complete Wegovy and Mounjaro Dose Ranges
Accessing the full spectrum of Wegovy and Mounjaro doses through EverydayMeds begins with our 3-minute online clinical assessment. Our MHRA-approved process captures essential medical history, current medications, and treatment goals to guide prescriber decision-making. Qualified prescribers review applications within 3 working days (express 24-hour service available), determining appropriate starting doses and escalation protocols. Once approved, all dose strengths ship via next-day delivery using cold-chain temperature-controlled logistics. Our GPhC-registered pharmacy (#9012878) maintains comprehensive stock levels across all dose ranges, ensuring immediate dispatch without waiting periods.
Storage and Practical Considerations: Wegovy vs Mounjaro Dose Comparison
Storage requirements present a key practical difference in the Wegovy and Mounjaro dose comparison. Wegovy pens maintain stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage proves particularly valuable during travel or when refrigeration access is limited. Both medications use pre-filled FlexTouch-style pens for convenient once-weekly injection, with clear dose indicators across all strengths. The refrigerated storage requirement (2-8°C) applies to both treatments, but Wegovy's extended room temperature tolerance provides superior flexibility for active lifestyles throughout the complete dose escalation journey.
Comprehensive Dose Continuity: Your Complete Treatment Partnership
The advantage of accessing complete Wegovy and Mounjaro dose ranges through a single pharmacy extends beyond convenience to treatment optimisation. Many patients require dose adjustments, temporary reductions, or extended time at specific strengths based on individual response and tolerance. Having immediate access to all dose options enables responsive treatment management without delays or pharmacy switching complications.
Our comprehensive inventory approach recognises that weight management represents a long-term commitment requiring flexible dosing strategies. Some patients benefit from extended periods at intermediate doses, whilst others progress rapidly through the escalation schedule. This individualised approach is only possible when all dose strengths remain continuously available, supporting both standard protocols and personalised treatment modifications as clinically indicated.
Expert Guidance for Wegovy and Mounjaro Dose Selection
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment and dosing approach aligns with your individual circumstances. The decision involves considering factors beyond simple dose comparison, including injection frequency preferences, side effect profiles, and long-term treatment goals. Our clinical team provides ongoing support throughout your complete dose journey, from initial starter strengths through maintenance therapy. Professional guidance ensures optimal outcomes whilst maintaining safety across all treatment phases. Contact our GPhC-registered pharmacy (#9012878) to begin your comprehensive weight management journey with complete dose range access and expert clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
